Work

Phase II study of dose-attenuated bortezomib, cyclophosphamide and dexamethasone (“VCD-Lite”) in very old or otherwise toxicity-vulnerable adults with newly diagnosed multiple myeloma

Year: 2017

Type: article

Study design: Clinical Trial

Source: Journal of Geriatric Oncology

DOI: 10.1016/j.jgo.2017.02.004

Authors: Sascha A. Tuchman, Joseph O. Moore, Carlos D. DeCastro, Zhiguo Li, Emily Sellars, Yubin Kang, Gwynn Long, Cristina G. Gasparetto

Institutions: University of North Carolina at Chapel Hill, Duke University, Duke Cancer Institute, UNC Lineberger Comprehensive Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2592711228

FWCI: 1.264

Cites: 26

Cited by: 11

Related to: 10